Uhomoibhi J O, Idowu K A, Shode F O, Sabiu S
Department of Biotechnology and Food Science, Faculty of Applied Sciences, Durban University of Technology (DUT), PO Box 1334, Durban, 4000, South Africa.
Sci Afr. 2022 Sep;17:e01279. doi: 10.1016/j.sciaf.2022.e01279. Epub 2022 Jul 14.
Coronavirus disease 2019 (COVID-19) pandemic, caused by the Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) is one of the major health threats the world has experienced. In order to stem the tide of the virus and its associated disease, rapid efforts have been dedicated to identifying credible anti-SARS-CoV-2 drugs. This study forms part of the continuing efforts to develop anti-SARS-CoV-2 molecules and employed a computational structure-activity relationship approach with emphasis on 99 plant secondary metabolites from eight selected African medicinal plants with proven therapeutic benefits against respiratory diseases focusing on the viral protein targets [Spike protein (Sgp), Main protease (Mpro), and RNA-dependent RNA polymerase (RdRp)]. The results of the molecular dynamics simulation of the best docked compounds presented as binding free energy revealed that three compounds each against the Sgp (VBS, COG and ABA), and Mpro (COR, QOR and ABG) had higher and better affinity for the proteins than the respective reference drugs, cefoperazone (CSP) and Nelfinavir (NEF), while four compounds (HDG, VBS, COR and KOR) had higher and favorable binding affinity towards RdRp than the reference standard, ramdesivir (RDS). Analysis of interaction with the receptor binding domain amino acid residues of Sgp showed that VBS had the highest number of interactions (17) relative to 14 and 13 for COG and ABA, respectively. For Mpro, COR showed interactions with catalytic dyad residues (His172 and Cys145). Compared to RDS, COR, HDG, VBS and KOR formed 19, 18, 17 and 12 H-bond and Van der Waal bonds, respectively, with RdRp. Furthermore, structural examination of the three proteins after binding to the lead compounds revealed that the compounds formed stable complexes. These observations suggest that the identified compounds might be beneficial in the fight against COVID-19 and are suggested for further and experimental validation.
2019冠状病毒病(COVID-19)大流行由严重急性呼吸综合征冠状病毒2(SARS-CoV-2)引起,是世界所经历的主要健康威胁之一。为了遏制病毒及其相关疾病的蔓延,人们迅速致力于寻找可靠的抗SARS-CoV-2药物。本研究是开发抗SARS-CoV-2分子持续努力的一部分,采用了计算结构-活性关系方法,重点研究了来自8种选定非洲药用植物的99种植物次生代谢产物,这些植物对呼吸系统疾病具有已证实的治疗益处,聚焦于病毒蛋白靶点[刺突蛋白(Sgp)、主要蛋白酶(Mpro)和RNA依赖性RNA聚合酶(RdRp)]。以结合自由能表示的最佳对接化合物的分子动力学模拟结果表明,针对Sgp(VBS、COG和ABA)和Mpro(COR、QOR和ABG)的三种化合物对蛋白质的亲和力高于各自的参考药物头孢哌酮(CSP)和奈非那韦(NEF),而四种化合物(HDG、VBS、COR和KOR)对RdRp的结合亲和力高于参考标准瑞德西韦(RDS)。与Sgp受体结合域氨基酸残基的相互作用分析表明,VBS的相互作用数量最多(17个),而COG和ABA分别为14个和13个。对于Mpro,COR与催化二元残基(His172和Cys145)有相互作用。与RDS相比,COR、HDG、VBS和KOR分别与RdRp形成了19、18、17和12个氢键和范德华键。此外,三种蛋白质与先导化合物结合后的结构检查表明,这些化合物形成了稳定的复合物。这些观察结果表明,所鉴定的化合物可能对对抗COVID-19有益,并建议进行进一步的实验验证。